Evidence map›Paper›PMID 28570507›Full record

ArticleMMWR. Morbidity and mortality weekly report2017

Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015.

Andrew F Auld, Ray W Shiraishi, Ikwo Oboho, Christine Ross, Moses Bateganya, Valerie Pelletier, Jacob Dee, Kesner Francois, Nirva Duval, Mayer Antoine and 87 more

Abstract read
In one paragraph

Article in MMWR. Morbidity and mortality weekly report, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. CD4+ T-Cell Count at Antiretroviral Therapy Initiation in the "Treat-All" Era in Rural South Africa: An Interrupted Time Series Analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  18. Performance Evaluation of BD FACSPrestoDiagnostics (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

97 authors.

Andrew F Auld
Ray W Shiraishi
Ikwo Oboho
Christine Ross
Moses Bateganya
Valerie Pelletier
Jacob Dee
Kesner Francois
Nirva Duval
Mayer Antoine
Chris Delcher
Gracia Desforges
Mark Griswold
Jean Wysler Domercant
Nadjy Joseph
Varough Deyde
Yrvel Desir
Joelle Deas Van Onacker
Ermane Robin
Helen Chun
Isaac Zulu
Ishani Pathmanathan
E Kainne Dokubo
Spencer Lloyd
Rituparna Pati
Jonathan Kaplan
Elliot Raizes
Thomas Spira
Kiren Mitruka
Aleny Couto
Eduardo Samo Gudo
Francisco Mbofana
Melissa Briggs
Charity Alfredo
Carla Xavier
Alfredo Vergara
Ndapewa Hamunime
Simon Agolory
Gram Mutandi
Naemi N Shoopala
Souleymane Sawadogo
Andrew L Baughman
Adebobola Bashorun
Ibrahim Dalhatu
Mahesh Swaminathan
Dennis Onotu
Solomon Odafe
Oseni Omomo Abiri
Henry H Debem
Hank Tomlinson
Velephi Okello
Peter Preko
Trong Ao
Caroline Ryan
George Bicego
Peter Ehrenkranz
Harrison Kamiru
Harriet Nuwagaba-Biribonwoha
Gideon Kwesigabo
Angela A Ramadhani
Kahemele Ng'wangu
Patrick Swai
Mohamed Mfaume
Ramadhani Gongo
Deborah Carpenter
Timothy D Mastro
Carol Hamilton
Julie Denison
Fred Wabwire-Mangen
Olivier Koole
Kwasi Torpey
Seymour G Williams
Robert Colebunders
Julius N Kalamya
Alice Namale
Michelle R Adler
Bridget Mugisa
Sundeep Gupta
Sharon Tsui
Eric van Praag
Duc B Nguyen
Sheryl Lyss
Yen Le
Abu S Abdul-Quader
Nhan T Do
Modest Mulenga
Sebastian Hachizovu
Owen Mugurungi
Beth A Tippett Barr
Elizabeth Gonese
Tsitsi Mutasa-Apollo
Shirish Balachandra
Stephanie Behel
Trista Bingham
Duncan Mackellar
David Lowrance
Tedd V Ellerbrock

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monitoring prevalence of advanced human immunodeficiency virus (HIV) disease (i.e., CD4+ T-cell count <200 cells/μL) among persons starting antiretroviral therapy (ART) is important to understand ART program outcomes, inform HIV prevention strategy, and forecast need for adjunctive therapies.*

Indexed as

AfricaAnti-Retroviral AgentsCD4 Lymphocyte CountHaitiHIV InfectionsHumansPrevalenceVietnamAnti-Retroviral Agents

Identifiers

PMID28570507
PMCPMC5657820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.